Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The medtech giant announced 6% revenue growth, led by the cardiac and vascular and diabetes groups, both of which are enjoying strong market demand for new products. Medtronic expects to continue growing revenues by about five percent annually to maintain double-digit earnings growth.
Latest From Companies
As the earnings season continues, Medtech Insight takes a look at dental firm Straumann’s performance, as well as that of some mid- to small-cap companies – including extremities implant specialist Wright Medical – highlighting which we believe to be the season’s winners and losers.
Siemens Healthineers is set to launch a new digital platform for healthcare providers and technology companies to share data, applications and services. The company presented a prototype of the new digital platform at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida.
A new implantable cell-based monitoring device that measure cellular interactions in vivo could soon reach the research market to help medical device and pharma companies in their preclinical, and later this year clinical, research. After that, the technology's developer, Efferent Labs, will be setting its sights on clinical applications like chemotherapy monitoring in cancer patients.
An analytics platform developed by Israeli big data company Intensix has shown high accuracy for detecting and predicting sepsis in critical care. The positive results were presented at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida.
Only a month after buying the tissue regeneration company Derma Sciences, Integra has announced a much larger acquisition for Codman Neurosurgery. The company says the buy would complement its current neurosurgery portfolio and boost its global reach.
Zeltiq's CoolSculpting body-contouring system will be the third "pillar" in Allergan's aesthetics business, along with its existing facial aesthetics and plastic and regenerative surgery lines, the company says.
Many medtech companies reported their sales and earnings for all of 2016, along with projections for 2017, at the end of January or early February. Medtech Insight has examined their reports as well as the comments of the analysts who track these companies to highlight a few that had especially good years, some that had down years, and some lesser-known companies worth watching in the future.
2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.
Having started out as a specialist in high-level medtech R&D and manufacturing in Turkey, Alvimedica has evolved to become a player in the interventional cardiology market with a portfolio of stents, balloons and catheters. It now has its eye on the $2.6bn US therapeutic interventional cardiology market for its Cre8 EVO drug-eluting stent.
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.